209 related articles for article (PubMed ID: 11162720)
41. Background DNA damage for endogenous and unavoidable exogenous carcinogens: a basis for spontaneous cancer incidence?
Gupta RC; Lutz WK
Mutat Res; 1999 Mar; 424(1-2):1-8. PubMed ID: 10232953
[TBL] [Abstract][Full Text] [Related]
42. DNA adducts: endogenous and induced.
Povey AC
Toxicol Pathol; 2000; 28(3):405-14. PubMed ID: 10862557
[TBL] [Abstract][Full Text] [Related]
43. Future research directions in the use of biomarkers.
Hemminki K; Kumar R; Bykov VJ; Louhelainen J; Vodicka P
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):459-64. PubMed ID: 8781364
[TBL] [Abstract][Full Text] [Related]
44. Carcinogen macromolecular adducts and their measurement.
Poirier MC; Santella RM; Weston A
Carcinogenesis; 2000 Mar; 21(3):353-9. PubMed ID: 10688855
[TBL] [Abstract][Full Text] [Related]
45. Methodologies for measuring carcinogen adducts in humans.
Strickland PT; Routledge MN; Dipple A
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):607-19. PubMed ID: 8268781
[TBL] [Abstract][Full Text] [Related]
46. The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: perspective, prospects and problems.
Loechler EL
Carcinogenesis; 1996 May; 17(5):895-902. PubMed ID: 8640935
[TBL] [Abstract][Full Text] [Related]
47. DNA adducts in model systems and humans.
Turteltaub KW; Frantz CE; Creek MR; Vogel JS; Shen N; Fultz E
J Cell Biochem Suppl; 1993; 17F():138-48. PubMed ID: 8412185
[TBL] [Abstract][Full Text] [Related]
48. Dose-response relationships for carcinogens.
Swenberg JA; La DK; Scheller NA; Wu KY
Toxicol Lett; 1995 Dec; 82-83():751-6. PubMed ID: 8597138
[TBL] [Abstract][Full Text] [Related]
49. Molecular approach in cancer epidemiology: early detection of carcinogen-induced mutations in a whole genome (Review).
Burnouf D; Miturski R; Nagao M; Nakagama H; Nothisen M; Wagner J; Fuchs RP
Int J Mol Med; 2000 Jan; 5(1):15-20. PubMed ID: 10601568
[TBL] [Abstract][Full Text] [Related]
50. Exocyclic DNA adducts as biomarkers of lipid oxidation and predictors of disease. Challenges in developing sensitive and specific methods for clinical studies.
Medeiros MH
Chem Res Toxicol; 2009 Mar; 22(3):419-25. PubMed ID: 19166334
[TBL] [Abstract][Full Text] [Related]
51. Monitoring of human exposure to carcinogens through DNA and protein adduct determination.
Farmer PB
Toxicol Lett; 1995 Dec; 82-83():757-62. PubMed ID: 8597139
[TBL] [Abstract][Full Text] [Related]
52. DNA adducts and mutations in occupational and environmental biomonitoring.
Hemminki K
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):823-7. PubMed ID: 9255567
[TBL] [Abstract][Full Text] [Related]
53. PCR-based approaches to adduct analysis.
Pfeifer GP; Denissenko MF; Tang MS
Toxicol Lett; 1998 Dec; 102-103():447-51. PubMed ID: 10022294
[TBL] [Abstract][Full Text] [Related]
54. Human Biomonitoring of DNA Adducts by Ion Trap Multistage Mass Spectrometry.
Guo J; Turesky RJ
Curr Protoc Nucleic Acid Chem; 2016 Sep; 66():7.24.1-7.24.25. PubMed ID: 27584705
[TBL] [Abstract][Full Text] [Related]
55. DNA damage studies related to the assessment of the role of N-nitroso compounds in human cancer.
Kyrtopoulos SA; Souliotis VL; Chhabra SK; Anderson LM
Eur J Cancer Prev; 1996 Sep; 5 Suppl 1():109-14. PubMed ID: 8972304
[No Abstract] [Full Text] [Related]
56. Biomarkers.
Pluygers EP
Med Lav; 1995; 86(3):278-83. PubMed ID: 7565293
[No Abstract] [Full Text] [Related]
57. DNA adducts of nitrosamines.
Shuker DE; Bartsch H
IARC Sci Publ; 1994; (125):73-89. PubMed ID: 7806342
[No Abstract] [Full Text] [Related]
58. Symposium on the significance of low level exposures to DNA adduct inducing chemicals, Department of Health, London, UK, May 1996.
Mulholland C; Battershill J; Fielder RJ
Mutagenesis; 1997 Jul; 12(4):305-12. PubMed ID: 9237778
[No Abstract] [Full Text] [Related]
59. What is the significance of increases in background levels of carcinogen-derived protein and DNA adducts? Some considerations for incremental risk assessment.
Farmer PB; Shuker DE
Mutat Res; 1999 Mar; 424(1-2):275-86. PubMed ID: 10064867
[TBL] [Abstract][Full Text] [Related]
60. Methods for measuring DNA adducts and abasic sites I: isolation, purification, and analysis of DNA adducts in intact DNA.
Swenberg JA; Ham AJ; McDorman KS; Morinello EJ; Nakamura J; Schoonhoven R
Curr Protoc Toxicol; 2002 Aug; Chapter 3():Unit3.8. PubMed ID: 23045079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
